611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net
Medical Disorders
Resources
Basic InformationLookupsLatest News
CDC to Advise Return to Masks Indoors for Some Vaccinated AmericansSevere COVID for People Under 45: Who's Most at Risk?The Heat Is On: Staying Safe When Temperatures SoarWho's Most Likely to Refuse a COVID Vaccine?Second COVID Shot Safe in Folks Who Had Allergic Reaction to FirstHigh Blood Pressure: Which Drug Works Best for You?Pfizer, Moderna to Expand Vaccine Studies in Young ChildrenFederal, State Moves Begin to Mandate COVID Vaccines for WorkersCan COVID Transmit Easily on Crowded School Buses?Worried About Delta-Linked 'Breakthrough' Infections? Experts Explain the RisksMajor Medical Groups Call for Mandatory COVID Vaccination for Health WorkersU.S. to Stick With International Travel RestrictionsSurvey Finds U.S. Parents Split on COVID Vaccination for Kids Under 12Most Unvaccinated Americans Want to Stay That Way: PollIt's Tick Season: Protect Yourself From Lyme DiseaseHigh-Tech Exoskeletons Improve Bowel Function in People With Spinal Cord Injury'Superbug' Fungus Spreads Among Vulnerable in Two U.S. CitiesVaccinations Start to Climb in States Hit Hard by Delta VariantAs Olympics Begin, Tokyo Posts Highest Number of New COVID Cases in Six MonthsVirtual Roller Coaster Ride Study Brings New Insights Into MigraineBiden Says Full Approval for COVID Vaccines Coming SoonPfizer Vaccine Offers 88% Protection Against Delta Variant, But 2 Doses NeededSecret Weapon: Why the 2nd Dose of Pfizer Vaccine Is So CrucialIn a First for the Continent, Pfizer COVID-19 Vaccine Will Be Produced in South AfricaLockdowns' Effects on Health Still Less Than Harm From Pandemic: ExpertsCOVID Drove Biggest Drop in U.S. Life Expectancy Since World War IIJ&J Vaccine Weak Against Delta Variant, 2nd Dose May Be NeededDouble Trouble: Wildfire Smoke Could Boost Odds for COVID's SpreadStatin Users May Have Added Protection Against Severe COVID-19Severe COVID in Kids: Rare, but Brain Issues Can ResultOne-Dose Blood Thinner Could Slash Blood Clot Risk After Knee ReplacementU.S. Issues Toughest Travel Alert for Britain As COVID Cases There ClimbPediatricians' Group: All School Kids, Staff Should Continue to Wear MasksGeneticists Probe Origins of Painful Cluster HeadachesAny COVID Infection Leaves Strong Antibody Levels in KidsMany Hit Hard by Pandemic Now Swamped by Medical DebtU.S. Surgeon General Backs Local Mask Mandates When NeededMake Summer Camp Safe for Your Child With Asthma, AllergiesCanada May Open Borders to Fully Vaccinated Americans by Mid-AugustCDC Advisors to Discuss 3rd COVID Vaccine Dose for ImmunocompromisedFDA to Prioritize Full Approval for Pfizer COVID VaccineEven a Little Lead in Drinking Water Can Harm People With Kidney DiseaseStatin's Health Benefits Far Outweigh  Any Potential Harms: StudyMore Than a Quarter of Long COVID Patients Still Not Recovered After 6 MonthsWhy Many Black & Hispanic Americans Distrust COVID VaccinesA Better Test to Help Spot Glaucoma?U.S. Surgeon General Issues Call to Counter 'Urgent Threat' of Vaccine MisinformationFriends, Family Key to Turning a 'No' on Vaccination to a 'Yes'AHA News: How Healthy Is Your Neighborhood? Where You Live Can Greatly Affect Heart, Brain HealthHeart Troubles Ease Over Time in Kids With MIS-C
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Secret Weapon: Why the 2nd Dose of Pfizer Vaccine Is So Crucial

HealthDay News
by By Ernie Mundell and Robert Preidt HealthDay Reporters
Updated: Jul 21st 2021

new article illustration

WEDNESDAY, July 21, 2021 (HealthDay News) -- It takes two doses of the Pfizer-BioNTech COVID-19 vaccine to "wake up" cells that play a very important role in the body's immune response, with the second dose increasing their numbers 100-fold, according to new research.

The Stanford University study may help explain why getting the second dose of mRNA vaccines, such as the Pfizer or Moderna shots, is so crucial to building a strong immune system response against SARS-CoV-2.

As study co-author Bali Pulendran explained, the current pandemic marks "the first time RNA vaccines have ever been given to humans, and we have no clue as to how they do what they do: offer 95% protection against COVID-19." Pulendran is professor of pathology and of microbiology and immunology at Stanford.

It's never been clear how mRNA-based vaccines offer recipients such extraordinarily high levels of protection against the new coronavirus. In comparison, a seasonal influenza vaccine is judged to be quite effective if it reaches even 60% protection.

In their investigation, the Stanford team analyzed blood samples from 56 healthy volunteers at multiple points before and after they received their first and second shots of the Pfizer vaccine.

The results showed that the first shot increased SARS-CoV-2-specific antibody levels, but not nearly as much as the second shot.

"The second shot has powerful beneficial effects that far exceed those of the first shot," Pulendran said in a university news release. "It stimulated a manifold increase in antibody levels, a terrific T-cell response that was absent after the first shot alone, and a strikingly enhanced innate immune response."

The researchers also looked at immune system players besides the standard antibodies that are usually studied.

When they did this, intriguing new details emerged: The second shot appears to do things the first shot cannot, according to the study published July 12 in the journal Nature.

The Stanford team was surprised to find that a second dose of Pfizer vaccine triggered a significant mobilization of a small group of first-responder immune cells that are normally scarce and dormant.

These cells are a small subset of normally abundant cells called monocytes, which produce high levels of genes with virus-fighting power.

When the COVID-19 virus infects a person these monocytes are barely activated, if at all, the researchers found.

However, the study showed that monocytes do respond strongly to the vaccine -- but primarily only after the second dose.

According to Pulendran's group, the monocytes accounted for just 0.01% of all circulating blood cells before vaccination, but their numbers increased 100-fold after the second dose of Pfizer vaccine, when they comprised a full 1% of all blood cells.

Also, the cells became less inflammatory and more strongly antiviral, and appear capable of providing broad protection against a range of viral infections, according to Pulendran.

"The extraordinary increase in the frequency of these cells, just a day following booster immunization, is surprising," he said. "It's possible that these cells may be able to mount a holding action against not only SARS-CoV-2, but against other viruses as well."

Already, studies are showing that strong immune responses against SARS-CoV-2 may last at least eight months, and possibly for years, in people who've received two doses of mRNA vaccines.

Dr. Amesh Adalja is an infectious disease expert and senior scholar with the Center for Health Security at Johns Hopkins University in Baltimore. He wasn't involved in the new study, but said it again "demonstrates that the second dose of the mRNA vaccine regimens augments, significantly, the immunity in general provided by the first dose.

"This is the rationale for a two-dose regimen, and why people who are fully vaccinated are more protected than individuals who are partially vaccinated," Adalja said. "I suspect the findings would be very similar with the Moderna vaccine since they use similar technology."

More information

The U.S. Centers for Disease Control and Prevention has more on mRNA COVID-19 vaccines.

SOURCES: Amesh Adalja, MD, senior scholar, Center for Health Security, Johns Hopkins University, Baltimore; Stanford University School of Medicine, news release, July 17, 2021